Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 73,468 | 70,008 | 62,465 | 59,867 | 67,771 |
| Cost of Goods | 8,177 | 7,115 | 8,574 | 5,552 | 6,035 |
| Gross Profit | 65,291 | 62,893 | 53,891 | 54,315 | 61,736 |
| Operating Expenses | 34,794 | 33,679 | 28,189 | 61,042 | 45,449 |
| Operating Income | 30,674 | 29,329 | 26,276 | -6,175 | 16,322 |
| Interest Expense | 1,099 | 1,117 | 1,067 | 1,146 | 1,208 |
| Other Income | 2,387 | -6,056 | -860 | 8,494 | -307 |
| Pre-tax Income | 31,962 | 22,156 | 24,349 | 1,173 | 14,807 |
| Income Tax | 411 | 643 | 1,005 | -256 | 457 |
| Net Income Continuous | 31,551 | 21,513 | 23,344 | 1,429 | 14,350 |
| Net Income | $31,551 | $21,513 | $23,344 | $1,429 | $14,350 |
| EPS Basic Total Ops | 0.24 | 0.16 | 0.17 | N/A | 0.10 |
| EPS Basic Continuous Ops | 0.24 | 0.16 | 0.17 | 0.01 | 0.10 |
| EPS Diluted Total Ops | 0.23 | 0.16 | 0.16 | N/A | 0.10 |
| EPS Diluted Continuous Ops | 0.23 | 0.16 | 0.16 | 0.01 | 0.10 |
| EPS Diluted Before Non-Recurring Items | 0.23 | 0.16 | 0.16 | 0.09 | 0.10 |
| EBITDA(a) | $35,539 | $34,193 | $31,132 | $-1,313 | $21,215 |